Sarepta Therapeutics, Inc. Annual Current State and Local Tax Expense (Benefit) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Sarepta Therapeutics, Inc. quarterly/annual Current State and Local Tax Expense (Benefit) history and growth rate from 2017 to 2023.
  • Sarepta Therapeutics, Inc. Current State and Local Tax Expense (Benefit) for the quarter ending December 31, 2023 was -$19.6M.
  • Sarepta Therapeutics, Inc. Current State and Local Tax Expense (Benefit) for the twelve months ending December 31, 2023 was $11.1M.
  • Sarepta Therapeutics, Inc. annual Current State and Local Tax Expense (Benefit) for 2023 was $11.1M, a 15.8% decline from 2022.
  • Sarepta Therapeutics, Inc. annual Current State and Local Tax Expense (Benefit) for 2022 was $13.2M.
  • Sarepta Therapeutics, Inc. annual Current State and Local Tax Expense (Benefit) for 2021 was -$40K, a 106% decline from 2020.
Current State and Local Tax Expense (Benefit), Trailing 12 Months (USD)
Current State and Local Tax Expense (Benefit), Annual (USD)
Current State and Local Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $11.1M -$2.08M -15.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $13.2M +$13.2M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$40K -$664K -106% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $624K +$103K +19.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $521K +$1.04M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
2018 -$521K -$2.38M -128% Jan 1, 2018 Dec 31, 2018 10-K 2022-03-01
2017 $1.86M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.